News Release

 

 

Evan Myrianthopoulos
Chief Financial Officer
DOR BioPharma, Inc.
850 Bear Tavern Road, Suite 201
Ewing, New Jersey 08628
Tel: 609-538-8200
Fax: 609-538-8205
email

 

 

 

 
 
 
 


INVESTOR CENTER

DOR BioPharma, Inc.’s common stock is listed on the Over The Counter Bulletin Board® securities market under the symbol DORB. Stockholders and interested parties are urged to contact our main office in Ewing, New Jersey at 609-538-8200 or send an e-mail to ir@dorbiopharma.com for further information.

FINANCIAL INFORMATION

DOR BioPharma Stock Quote (Over -The- Counter bulletin board securities market, symbol “DORB” ).
DOR BioPharma Filings with the SEC (link to EDGAR DATABASE)
DOR BioPharma Financial Releases
Code of Ethics for Senior Financial Officers

10QSB

Provides a comprehensive review of DOR BioPharma's financial position and operating results for the quarter and year-to-date. Offers a discussion of business activities, information about earnings and other measures of financial performance and unaudited financial statements and statistical data.
LINK to 10QSB on the EDGAR database

10KSB

Provides a description of DOR BioPharma's businesses, products and services, a comprehensive review of the company's financial position and operating results for the year, a discussion of business activities, information about earnings and other measures of financial performance and audited financial statements and footnotes. 
LINK to 10KSB on the EDGAR database

LITERATURE REQUEST:

If you would like to receive our Investor Relations Packet, including reprints of scientific publications relating to our products, please fill out the following form and click on “Submit”. Thank you for your interest.

 

   
  Legal Notice
  Copyright © 2005 DOR BioPharma, Inc. 1999-2005 All rights reserved.